Shin Nippon Biomedical Laboratories, Ltd. (TYO:2395)

TYO:2395 Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	9,923	10,274	10,533	6,628	7,230	5,249
Short-Term Investments	134.22	336	-	368	55	-
Cash & Short-Term Investments	10,058	10,610	10,533	6,996	7,285	5,249
Cash Growth	-22.65%	0.73%	50.56%	-3.97%	38.79%	2.10%
Receivables	6,278	5,722	4,695	3,499	2,952	2,534
Inventory	14,209	12,373	7,329	4,359	4,071	4,031
Other Current Assets	2,317	2,132	1,342	1,280	472	595
Total Current Assets	32,862	30,837	23,899	16,134	14,780	12,409
Property, Plant & Equipment	33,908	26,357	18,879	13,155	12,897	13,699
Long-Term Investments	25,887	15,926	12,404	8,645	8,522	12,242
Goodwill	1,855	1,934	1,438	-	-	-
Other Intangible Assets	240.98	225	261	212	213	194
Long-Term Deferred Tax Assets	-	989	325	1,129	521	1
Other Long-Term Assets	2,544	2	2	1	2	2
Total Assets	97,297	76,302	57,242	39,312	36,972	39,002
Accounts Payable	556.35	460	419	64	95	119
Short-Term Debt	10,551	7,826	8,923	2,942	3,486	5,998
Current Income Taxes Payable	1,331	1,701	603	743	683	502
Other Current Liabilities	14,736	13,580	11,066	9,624	7,651	6,332
Total Current Liabilities	27,174	23,567	21,011	13,373	11,915	12,951
Long-Term Debt	23,390	18,147	9,480	5,809	8,669	8,217
Long-Term Leases	147.14	212	357	385	529	707
Long-Term Deferred Tax Liabilities	-	84	-	-	-	726
Other Long-Term Liabilities	1,495	133	36	22	20	21
Total Liabilities	52,206	42,143	30,884	19,589	21,133	22,622
Common Stock	9,679	9,679	9,679	9,679	9,679	9,679
Additional Paid-In Capital	2,358	2,358	2,306	2,306	2,306	5,196
Retained Earnings	18,340	17,215	13,766	10,196	3,854	-2,489
Comprehensive Income & Other	14,611	4,861	460	-2,620	-104	3,901
Total Common Equity	44,988	34,113	26,211	19,561	15,735	16,287
Minority Interest	102.04	46	147	162	104	93
Shareholders' Equity	45,090	34,159	26,358	19,723	15,839	16,380
Total Liabilities & Equity	97,297	76,302	57,242	39,312	36,972	39,002
Total Debt	34,088	26,185	18,760	9,136	12,684	14,922
Net Cash (Debt)	-24,031	-15,575	-8,227	-2,140	-5,399	-9,673
Net Cash Per Share	-577.22	-374.12	-197.62	-51.40	-129.68	-232.35
Filing Date Shares Outstanding	41.63	41.63	41.63	41.63	41.63	41.63
Total Common Shares Outstanding	41.63	41.63	41.63	41.63	41.63	41.63
Working Capital	5,688	7,270	2,888	2,761	2,865	-542
Book Value Per Share	1080.62	819.40	629.59	469.85	377.95	391.21
Tangible Book Value	42,893	31,954	24,512	19,349	15,522	16,093
Tangible Book Value Per Share	1030.29	767.54	588.78	464.76	372.84	386.55
Order Backlog	-	34,404	29,249	19,724	13,447	11,500

Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.